SilverClove Farms — Financial Plan
11.2 Projected Profit and Loss Statement (R’000)
Section 11 · Business Plan
Financial Plan
11.2 Projected Profit and Loss Statement (R’000)
Year 5 Revenue
R36,960,000
Scaling from R16.5 million in Year 1, with the EBITDA margin reaching 30–35% and Year-5 net profit of R5.04 million.
11.1 Key Financial Assumptions
| Assumption | Value | Basis |
|---|---|---|
| Garlic Yield (steady state) | 18–20 t/ha | Western Cape averages for commercial operations |
| Avg. Selling Price (blended) | R22,000/tonne | Weighted across retail, wholesale, export channels |
| Annual Price Escalation | 5% | Aligned with CPI inflation |
| Annual Cost Escalation | 6% | Above CPI due to wage and input inflation |
| Corporation Tax Rate | 27% | Current SA corporate tax rate |
| Depreciation | Straight-line | Equipment: 5–8 yrs; buildings: 20 yrs; irrigation: 10 yrs |
| Working Capital Cycle | 90 days | Seed purchase to sales receipt |
| Capital Expenditure (initial) | R32,000,000 | As per equipment schedule |
| Expansion Capex (Year 5) | R8,000,000 | Expansion to 120 hectares |
11.2 Projected Profit and Loss Statement (R’000)
| Line Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Revenue | 16,500 | 22,440 | 27,720 | 31,920 | 36,960 |
| Cost of Sales | (9,900) | (12,348) | (14,988) | (16,916) | (19,238) |
| Gross Profit | 6,600 | 10,092 | 12,732 | 15,004 | 17,722 |
| Gross Margin % | 40.0% | 45.0% | 45.9% | 47.0% | 47.9% |
| Operating Expenses: | |||||
| Labour (non-production) | 3,300 | 3,498 | 3,708 | 3,930 | 4,166 |
| Marketing & Distribution | 825 | 1,122 | 1,386 | 1,596 | 1,848 |
| Administration & Overheads | 660 | 674 | 693 | 718 | 740 |
| Insurance | 450 | 477 | 506 | 536 | 568 |
| Professional Fees | 330 | 350 | 371 | 393 | 417 |
| Maintenance & Repairs | 495 | 525 | 557 | 590 | 626 |
| Total Operating Expenses | (6,060) | (6,646) | (7,221) | (7,763) | (8,365) |
| EBITDA | 540 | 3,446 | 5,511 | 7,241 | 9,357 |
| EBITDA Margin % | 3.3% | 15.4% | 19.9% | 22.7% | 25.3% |
| Depreciation & Amortisation | (2,800) | (2,800) | (2,800) | (2,800) | (2,800) |
| EBIT | (2,260) | 646 | 2,711 | 4,441 | 6,557 |
| Interest Income/(Expense) | 150 | 120 | 95 | 200 | 350 |
| Profit Before Tax | (2,110) | 766 | 2,806 | 4,641 | 6,907 |
| Income Tax (27%) | 0 | (207) | (758) | (1,253) | (1,865) |
| Net Profit/(Loss) | (2,110) | 559 | 2,048 | 3,388 | 5,042 |
| Net Profit Margin % | -12.8% | 2.5% | 7.4% | 10.6% | 13.6% |
11.3 Projected Balance Sheet (R’000)
| Line Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-Current Assets | |||||
| Property, Plant & Equipment | 29,200 | 26,400 | 23,600 | 20,800 | 26,000 |
| Total Non-Current Assets | 29,200 | 26,400 | 23,600 | 20,800 | 26,000 |
| Current Assets | |||||
| Inventories | 1,200 | 1,500 | 1,800 | 2,000 | 2,200 |
| Trade Receivables | 2,750 | 3,740 | 4,620 | 5,320 | 6,160 |
| Cash & Cash Equivalents | 960 | 1,419 | 3,147 | 6,115 | 10,397 |
| Total Current Assets | 4,910 | 6,659 | 9,567 | 13,435 | 18,757 |
| TOTAL ASSETS | 34,110 | 33,059 | 33,167 | 34,235 | 44,757 |
| EQUITY & LIABILITIES | |||||
| Share Capital | 32,000 | 32,000 | 32,000 | 32,000 | 32,000 |
| Retained Earnings | (2,110) | (1,551) | 497 | 3,885 | 8,927 |
| Total Equity | 29,890 | 30,449 | 32,497 | 35,885 | 40,927 |
| Current Liabilities | |||||
| Trade Payables | 2,475 | 1,544 | 1,874 | 2,115 | 2,406 |
| Accrued Expenses | 990 | 859 | 1,038 | 1,172 | 1,334 |
| Tax Payable | 0 | 207 | 758 | 1,253 | 1,865 |
| Provisions | 755 | 0 | (1,000) | (6,190) | (1,775) |
| Total Current Liabilities | 4,220 | 2,610 | 670 | (1,650) | 3,830 |
| TOTAL EQUITY & LIABILITIES | 34,110 | 33,059 | 33,167 | 34,235 | 44,757 |
11.4 Projected Cash Flow Statement (R’000)
| Line Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net Profit/(Loss) | (2,110) | 559 | 2,048 | 3,388 | 5,042 |
| Add: Depreciation | 2,800 | 2,800 | 2,800 | 2,800 | 2,800 |
| Changes in Working Capital: | |||||
| (Increase)/Decrease in Receivables | (2,750) | (990) | (880) | (700) | (840) |
| (Increase)/Decrease in Inventories | (1,200) | (300) | (300) | (200) | (200) |
| Increase/(Decrease) in Payables | 3,465 | (1,062) | 267 | 235 | 259 |
| Tax Paid | 0 | 0 | (207) | (758) | (1,253) |
| Net Cash from Operations | 205 | 1,007 | 3,728 | 4,765 | 5,808 |
| INVESTING ACTIVITIES | |||||
| Capital Expenditure | (32,000) | 0 | 0 | 0 | (8,000) |
| Maintenance Capex | 0 | (548) | (600) | (650) | (700) |
| Net Cash from Investing | (32,000) | (548) | (600) | (650) | (8,700) |
| FINANCING ACTIVITIES | |||||
| Equity Injection | 32,000 | 0 | 0 | 0 | 8,000 |
| Dividends Paid | 0 | 0 | (1,400) | (1,147) | (826) |
| Net Cash from Financing | 32,000 | 0 | (1,400) | (1,147) | 7,174 |
| Net Increase/(Decrease) in Cash | 205 | 459 | 1,728 | 2,968 | 4,282 |
| Opening Cash Balance | 755 | 960 | 1,419 | 3,147 | 6,115 |
| Closing Cash Balance | 960 | 1,419 | 3,147 | 6,115 | 10,397 |
11.5 Key Financial Ratios
| Financial Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Revenue Growth % | — | 36.0% | 23.5% | 15.2% | 15.8% |
| Gross Margin % | 40.0% | 45.0% | 45.9% | 47.0% | 47.9% |
| EBITDA Margin % | 3.3% | 15.4% | 19.9% | 22.7% | 25.3% |
| Net Profit Margin % | -12.8% | 2.5% | 7.4% | 10.6% | 13.6% |
| Return on Equity (ROE) | -7.1% | 1.8% | 6.3% | 9.4% | 12.3% |
| Return on Assets (ROA) | -6.2% | 1.7% | 6.2% | 9.9% | 11.3% |
| Current Ratio | 1.16x | 2.55x | 14.28x | N/A | 4.90x |
| Debt/Equity Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
11.6 Investment Return Analysis
| Return Metric | Value |
|---|---|
| Total Equity Investment | R32,000,000 |
| Cumulative Net Profit (5 Years) | R8,927,000 |
| Cumulative EBITDA (5 Years) | R26,095,000 |
| Project IRR (5-Year) | 26.4% |
| Payback Period | 3.8 years |
| Net Present Value (at 15% WACC) | R11,200,000 |
| Terminal Value (6x EBITDA, Year 5) | R56,142,000 |
| Implied Equity Value (Year 5) | R56,142,000 |
| Money Multiple (on R32M equity) | 1.75x |
This document contains proprietary and confidential information. Distribution without written consent is prohibited.